MB
XERS icon

MPM BioImpact’s Xeris Biopharma Holdings XERS Stock Holding History

MPM BioImpact’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,830,526
Closed -$10.9M – 53
2024
Q2 		$10.9M Buy
4,830,526
+664,030
+16% +$1.34M 1.69% 21
2024
Q1 		$9.21M Buy
4,166,496
+319,264
+8% +$826K 1.48% 24
2023
Q4 		$9.04M Sell
3,847,232
-140,735
-4% -$260K 2.12% 22
2023
Q3 		$7.42M Buy
3,987,967
+12,968
+0.3% +$29.7K 1.98% 19
2023
Q2 		$10.4M Buy
+3,974,999
New +$10.1M 2.1% 16

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MPM BioImpact's XERS Position: Q3 2024 in Review

MPM BioImpact sold out of Xeris Biopharma Holdings (XERS) in Q3 2024, closing a stake of 4,830,526 shares — an estimated $10.9M sold.

MPM BioImpact first reported a position in XERS in Q2 2023 and held it in 5 quarters. The position peaked at $10.9M in Q2 2024. 144 funds tracked by Wall St. Rank hold XERS as of Q3 2024.

  • MPM BioImpact reported no remaining Xeris Biopharma Holdings position as of Q3 2024 after selling out during the quarter.
  • MPM BioImpact sold 4,830,526 Xeris Biopharma Holdings shares in Q3 2024, an estimated $10.9M.
  • MPM BioImpact first reported a position in Xeris Biopharma Holdings in Q2 2023 and held it in 5 quarters.
  • MPM BioImpact's Xeris Biopharma Holdings position peaked at $10.9M in Q2 2024.
  • 144 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2024.

Based on MPM BioImpact's 13F filing for Q3 2024, filed 13 Nov 2024.